Yeliz Bilir
Research Subjects
Yeliz Bilir has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Kemal Tolga Saracoglu
Department of Anaesthesiology, University of Florida UF Health Jacksonville, Jacksonville, USA
4 shared publications - Akın Bilir
Kartal Dr. Lütfi Kırdar City Hospital, Turkey
2 shared publications - Ayten Saracoglu
Department of Anesthesiology, University of Florida, UF Health, Jacksonville, FL 32209, USA
2 shared publications - Elif Bombacı
Intensive Care Clinic, Health Sciences University Kartal Dr Lutfi Kirdar City Hospital, Istanbul, Turkey
2 shared publications - Fulya Ciyiltepe
Department of Intensive Care, Antalya Training and Research Hospital, University of Health Sciences, Varlık Mahallesi, Kazım Karabekir Caddesi, Muratpaşa, 07100 Antalya, Türkiye
2 shared publications - Abdulkerim Yilmaz
Department of Chemical Engineering, Sivas Cumhuriyet University, Sivas, Turkey
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (1) , e20251019
The role of electrical impedance tomography in intensive care units: applications and clinical perspectives
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (1) , e20251019
Open AccessThe role of electrical impedance tomography in intensive care units: applications and clinical perspectives
- Open Access
- 26 September 2023
- Published by Turkish Society of Intensive Care in Turkish Journal of Intensive Care
- Vol. 21 (3) , 228-233
Effect of the Timing of Admission Upon Patient Prognosis in the Intensive Care Unit: Off-hours and On-hours
Amaç: Yoğun bakım üniteleri (YBÜ), kritik hastaların 24 saat boyunca dinamik olarak takip edildiği kliniklerdir. Bu çalışma; YBÜ’ye mesai içi (Mİ) ve mesai dışı (MD) zamanlarda yatan hastaların klinik özelliklerini ve sonuçlarını değerlendirmek amacıyla planlanmıştır. Gereç ve Yöntem: Bu çalışma için etik kurul onayı alındı. Temmuz 2021 ile Ocak 2022 tarihleri arasında erişkin YBÜ’lerinde yatan hastalar geriye dönük olarak değerlendirildi. Hastalar Mİ (grup Mİ; hafta içi 08.00-17.00) ve MD (grup MD; hafta içi 17.01-07.59, hafta sonları ve tatil günleri) kabul edilen olmak üzere iki gruba ayrıldı. Gruplar hasta özellikleri ve yoğun bakım sonuçları açısından karşılaştırıldı. Bulgular: Çalışmaya dahil edilen 173 hastanın %69,94’ü (n=121) MD, %30,05’i (n=52) Mİ zamanlarda takip edilmişlerdir. Hastaların medyan yaşı 70,3±9,5 yıl olup, %58,4’ü erkek, %41,6’sı kadındır. MD yatan hasta sayısı, Mİ yatan hasta sayısına göre istatistiksel olarak anlamlı daha yüksektir (p=0,04). MD yatan hastalarda komorbidite olarak kronik böbrek yetmezliğinin (%18,2, p=0,024) daha sık görülmesi dışında iki grup arasında demografik veriler açısından anlamlı fark yoktur. YBÜ’ye yatış nedenlerinden sürekli renal replasman terapi tedavisi ihtiyacı MD yatan hastalarda anlamlı daha yüksek olarak bulunmuştur (p=0,048). YBÜ gün sayısı ve entübe gün sayısı grup MD’de daha yüksek bulunmuştur (p=0,006, p=0,022). Hastaların %34,1 eksitus ile sonuçlanmıştır. Gruplar arasında mortalite ve taburculuk açısından anlamlı fark yoktur. Sonuç: Çalışmamızda YBÜ’lerde Mİ ve MD koşullarda takip edilen hastalarda klinik sonuçların benzer olduğu görüldü. Bu sonuç; hastanemizde nöbet ekibinin farklı olmamasına, deneyimli sağlık personeli sayısının fazla olmasına ve gerekli tanısal işlemlerin geciktirilmemesine bağlanabilir
- 26 September 2023
- Published by Turkish Society of Intensive Care in Turkish Journal of Intensive Care
- Vol. 21 (3) , 228-233
Open AccessEffect of the Timing of Admission Upon Patient Prognosis in the Intensive Care Unit: Off-hours and On-hours
Amaç: Yoğun bakım üniteleri (YBÜ), kritik hastaların 24 saat boyunca dinamik olarak takip edildiği kliniklerdir. Bu çalışma; YBÜ’ye mesai içi (Mİ) ve mesai dışı (MD) zamanlarda yatan hastaların klinik özelliklerini ve sonuçlarını değerlendirmek amacıyla planlanmıştır. Gereç ve Yöntem: Bu çalışma için etik kurul onayı alındı. Temmuz 2021 ile Ocak 2022 tarihleri arasında erişkin YBÜ’lerinde yatan hastalar geriye dönük olarak değerlendirildi. Hastalar Mİ (grup Mİ; hafta içi 08.00-17.00) ve MD (grup MD; hafta içi 17.01-07.59, hafta sonları ve tatil günleri) kabul edilen olmak üzere iki gruba ayrıldı. Gruplar hasta özellikleri ve yoğun bakım sonuçları açısından karşılaştırıldı. Bulgular: Çalışmaya dahil edilen 173 hastanın %69,94’ü (n=121) MD, %30,05’i (n=52) Mİ zamanlarda takip edilmişlerdir. Hastaların medyan yaşı 70,3±9,5 yıl olup, %58,4’ü erkek, %41,6’sı kadındır. MD yatan hasta sayısı, Mİ yatan hasta sayısına göre istatistiksel olarak anlamlı daha yüksektir (p=0,04). MD yatan hastalarda komorbidite olarak kronik böbrek yetmezliğinin (%18,2, p=0,024) daha sık görülmesi dışında iki grup arasında demografik veriler açısından anlamlı fark yoktur. YBÜ’ye yatış nedenlerinden sürekli renal replasman terapi tedavisi ihtiyacı MD yatan hastalarda anlamlı daha yüksek olarak bulunmuştur (p=0,048). YBÜ gün sayısı ve entübe gün sayısı grup MD’de daha yüksek bulunmuştur (p=0,006, p=0,022). Hastaların %34,1 eksitus ile sonuçlanmıştır. Gruplar arasında mortalite ve taburculuk açısından anlamlı fark yoktur. Sonuç: Çalışmamızda YBÜ’lerde Mİ ve MD koşullarda takip edilen hastalarda klinik sonuçların benzer olduğu görüldü. Bu sonuç; hastanemizde nöbet ekibinin farklı olmamasına, deneyimli sağlık personeli sayısının fazla olmasına ve gerekli tanısal işlemlerin geciktirilmemesine bağlanabilir
- Open Access
- 14 March 2023
- Published by Turkish Society of Intensive Care in Turkish Journal of Intensive Care
- Vol. 21 (1) , 55-58
Toxic Methemoglobinemia Caused by Prilocaine: Presentation of Two Cases
Prilokain, pek çok alanda kullanılan lokal anestetik bir ajandır, ancak hayatı tehdit edebilen bir yan etki olan methemoglobinemiye neden olabilmektedir. Bunun sonucunda dokularda hipoksi gelişebilir. Bu çalışmada radyoloji tarafından girişimsel işlem sırasında kullanılan lokal prilokaine bağlı gelişen iki toksik methemoglobinemi olgusu sunulmuştur. Methemoglobinemi ciddi bir hematolojik hastalık olup hemoglobindeki demirin okside olup, üç değerli (Fe+++) duruma geçmesiyle oluşur. Lokal anestezik kullanımından sonra, PaO2 ile SaO2 değerleri arasında uyumsuzluk veya siyanoz saptanması halinde ayırıcı tanıda methemoglobinemi akla getirilmelidir. Böyle durumlarda hastaların gelişebilecek problemler açısından tam donanımlı yoğun bakım ünitelerinde izlenmesi uygundur. Tedavide metilen mavisi ve askorbik asit başarıyla kullanılmaktadır. Bu yazıda lokal anestezi amacıyla prilokain kullanımına bağlı methemoglobinemi gelişen ve intravenöz metilen mavisi ve/veya askorbik asit ile tedavi edilen iki olgu sunulmuştur.
- 14 March 2023
- Published by Turkish Society of Intensive Care in Turkish Journal of Intensive Care
- Vol. 21 (1) , 55-58
Open AccessToxic Methemoglobinemia Caused by Prilocaine: Presentation of Two Cases
Prilokain, pek çok alanda kullanılan lokal anestetik bir ajandır, ancak hayatı tehdit edebilen bir yan etki olan methemoglobinemiye neden olabilmektedir. Bunun sonucunda dokularda hipoksi gelişebilir. Bu çalışmada radyoloji tarafından girişimsel işlem sırasında kullanılan lokal prilokaine bağlı gelişen iki toksik methemoglobinemi olgusu sunulmuştur. Methemoglobinemi ciddi bir hematolojik hastalık olup hemoglobindeki demirin okside olup, üç değerli (Fe+++) duruma geçmesiyle oluşur. Lokal anestezik kullanımından sonra, PaO2 ile SaO2 değerleri arasında uyumsuzluk veya siyanoz saptanması halinde ayırıcı tanıda methemoglobinemi akla getirilmelidir. Böyle durumlarda hastaların gelişebilecek problemler açısından tam donanımlı yoğun bakım ünitelerinde izlenmesi uygundur. Tedavide metilen mavisi ve askorbik asit başarıyla kullanılmaktadır. Bu yazıda lokal anestezi amacıyla prilokain kullanımına bağlı methemoglobinemi gelişen ve intravenöz metilen mavisi ve/veya askorbik asit ile tedavi edilen iki olgu sunulmuştur.
- 1 January 2023
- Vol. 27 (19) , 9001-9011
Discharge of dependent patients directly from the intensive care units after a critical illness: a single-center retrospective cohort study
OBJECTIVE: This study aimed to determine the mortality and predictive factors affecting mortality of patients discharged directly from the intensive care unit (ICU) at the third -and sixth-month post-discharge. Additionally, it assessed the rate of hospital readmissions with-in 30 days post-discharge and the satisfaction level of family members with post-ICU care.PATIENTS AND METHODS: In this single -center, retrospective, observational cohort study, de-pendent patients discharged directly from the ICU between July 1, 2019, and July 1, 2022, were included. Data on patients' demographics, reasons for admission, pre-existing diseases, length of ICU stay, advanced clinical interventions, dis-charge destination, physiological status on discharge, readmission within 30 days, and clinical outcomes and mortality at the third-and sixth -months post-discharge were collected.RESULTS: The study included 240 patients, rep-resenting 45.8% of all patients discharged directly from the ICU. Of these, 122 were discharged to their homes, and 118 to intermediate care units intermediate care units (IMCUs). The mean age was 71 years [interquartile range (IQR): 22.8]. Among the patients, 113 (47.1%) were readmitted with-in 30 days post-discharge, and 23 (20.35%) were re-hospitalized. The overall mortality rate in the third and sixth months was 25.4% and 32.5%, respectively. Logistic regression identified age, re-admission within 30 days, and Glasgow Outcome Scale-Extended (GOS-E) at discharge as predictive factors for short-term and long-term mortality. Patients discharged to IMCUs had significantly higher long-term mortality. Family members of patients discharged to their homes had significantly higher satisfaction with post-ICU care (p=0.002). CONCLUSIONS: Discharging patients directly from the ICU to their homes may yield better outcomes in selected patients compared to dis-charging to IMCUs. This approach may also enable more efficient use of hospital resources and reduce ICU occupancy and associated costs.
- 1 January 2023
- Vol. 27 (19) , 9001-9011
Discharge of dependent patients directly from the intensive care units after a critical illness: a single-center retrospective cohort study
OBJECTIVE: This study aimed to determine the mortality and predictive factors affecting mortality of patients discharged directly from the intensive care unit (ICU) at the third -and sixth-month post-discharge. Additionally, it assessed the rate of hospital readmissions with-in 30 days post-discharge and the satisfaction level of family members with post-ICU care.PATIENTS AND METHODS: In this single -center, retrospective, observational cohort study, de-pendent patients discharged directly from the ICU between July 1, 2019, and July 1, 2022, were included. Data on patients' demographics, reasons for admission, pre-existing diseases, length of ICU stay, advanced clinical interventions, dis-charge destination, physiological status on discharge, readmission within 30 days, and clinical outcomes and mortality at the third-and sixth -months post-discharge were collected.RESULTS: The study included 240 patients, rep-resenting 45.8% of all patients discharged directly from the ICU. Of these, 122 were discharged to their homes, and 118 to intermediate care units intermediate care units (IMCUs). The mean age was 71 years [interquartile range (IQR): 22.8]. Among the patients, 113 (47.1%) were readmitted with-in 30 days post-discharge, and 23 (20.35%) were re-hospitalized. The overall mortality rate in the third and sixth months was 25.4% and 32.5%, respectively. Logistic regression identified age, re-admission within 30 days, and Glasgow Outcome Scale-Extended (GOS-E) at discharge as predictive factors for short-term and long-term mortality. Patients discharged to IMCUs had significantly higher long-term mortality. Family members of patients discharged to their homes had significantly higher satisfaction with post-ICU care (p=0.002). CONCLUSIONS: Discharging patients directly from the ICU to their homes may yield better outcomes in selected patients compared to dis-charging to IMCUs. This approach may also enable more efficient use of hospital resources and reduce ICU occupancy and associated costs.
- Open Access
- 8 December 2022
- Published by MediHealth Academy in Kastamonu Medical Journal
- Vol. 2 (4) , 108-112
Burnout levels of the intensive care unit team during extended COVID-19 outbreak and affecting factors
Introduction: This study aimed to determine how intensive care workers are affected by the pandemic period and the factors affecting burnout. Methods: 45assistants, 76nurses and 40specialists working in a tertiary intensive care unit(ICU) with 70 covid-beds participated in the study. Responses were collected through a website(www.surveymonkey.com). Results: The mean age of the respondents was 34.4±8.6 years, and the mean years of experience were 9.4±8.2. The general Emotional Exhaustion(EE), Depersonalization(DP), Reduced Personal Achievement(RPA) scores of the ICU workers were calculated as 20.7, 8.4 and 20.1 and the general arithmetic mean of the burnout scores was 49.1. It was found that the assistant doctors(AD) group had a statistically significantly higher risk in the EE and DP scales. (p=0,016 p<0,001). It was found that the risk of EE was higher in AD Group without child. Considering the satisfaction correlation of the scales, The rate of dissatisfaction was found statistically significantly higher in the intensive care nurses(ICN) group than AD and specialist doctors(SD) groups (p<0,001). Considering the factors affecting burnout, a statistically significant negative correlation was found between EE and ‘Appreciation at work during the pandemic period’ and ‘Adequacy of physical conditions’ in the SD group (p=0,005 p=0,044). There was a statistically significant negative correlation between RPA and being married in the AD group (p=0,023). A statistically significant negative correlation was found between DP and having a child in the ICN group (p=0,032). Conclusion: It is of importance to reveal the causes of burnout during the pandemic, and to make arrangements Keywords: COVID-19, Intensive Care Unit, Assistant Doctor, Specialist Doctor, Burnout Burnout
- 8 December 2022
- Published by MediHealth Academy in Kastamonu Medical Journal
- Vol. 2 (4) , 108-112
Open AccessBurnout levels of the intensive care unit team during extended COVID-19 outbreak and affecting factors
Introduction: This study aimed to determine how intensive care workers are affected by the pandemic period and the factors affecting burnout. Methods: 45assistants, 76nurses and 40specialists working in a tertiary intensive care unit(ICU) with 70 covid-beds participated in the study. Responses were collected through a website(www.surveymonkey.com). Results: The mean age of the respondents was 34.4±8.6 years, and the mean years of experience were 9.4±8.2. The general Emotional Exhaustion(EE), Depersonalization(DP), Reduced Personal Achievement(RPA) scores of the ICU workers were calculated as 20.7, 8.4 and 20.1 and the general arithmetic mean of the burnout scores was 49.1. It was found that the assistant doctors(AD) group had a statistically significantly higher risk in the EE and DP scales. (p=0,016 p<0,001). It was found that the risk of EE was higher in AD Group without child. Considering the satisfaction correlation of the scales, The rate of dissatisfaction was found statistically significantly higher in the intensive care nurses(ICN) group than AD and specialist doctors(SD) groups (p<0,001). Considering the factors affecting burnout, a statistically significant negative correlation was found between EE and ‘Appreciation at work during the pandemic period’ and ‘Adequacy of physical conditions’ in the SD group (p=0,005 p=0,044). There was a statistically significant negative correlation between RPA and being married in the AD group (p=0,023). A statistically significant negative correlation was found between DP and having a child in the ICN group (p=0,032). Conclusion: It is of importance to reveal the causes of burnout during the pandemic, and to make arrangements Keywords: COVID-19, Intensive Care Unit, Assistant Doctor, Specialist Doctor, Burnout Burnout
- 15 March 2022
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 12 (2) , 233-237
Covıd-19 tanılı Geriatrik Yoğun Bakım Hastalarında D Vitamini Desteği Sitokin Fırtınasını ve Mortaliteyi Azaltır mı?
Introduction: Coronavirus disease progresses from an asymptomatic stage to a fatal stage characterized by a cytokine storm. Therefore, treatment should focus on enhancing the patients’immune function and preventing cytokine release syndrome. Vitamin-D deficiency is one of the factors triggering cytokine release syndrome. The present study aimed to emphasize the therapeutic effect of vitamin-D supplementation and its potential importance in reducing the disease severity in older adults in the intensive care unit after COVID-19 diagnosis. Materials and Method: The data of 80 patients aged ≥ 65 years who followed up in intensive care clinic. The inflammatory parameters and clinical course of 40 patients whose serum 25-hydroxyvitamin-D level was below 30ng/ml and who received vitamin-D supplementation (case-group) were recorded on the fifth and tenth days of follow-upand compared with those of the other 40 patients who were hospitalized during the initial period of the pandemic and who did not receive vitamin-D supplementation (control-group). Results: Cytokine release syndrome, has developed in the case group rarely. On the 10.day, levels of the inflammatory markers C-reactive protein, procalcitonin, D-dimer, ferritin, interleukin-6, and lactate dehydrogenase were significantly lower and the lymphocyte count was significantly higher in the case group than in the control group. On the 5.day, the interleukin-6 level was significantly lower in the case group. Weaning was performed in nine and four patients in the case and control groups, respectively. There was no significant difference in mortality rates between the groups. Conclusion: Vitamin-D supplementation can help reduce cytokine response. Recommended prophylactically or therapeutically at all stages of coronavirus disease.
- 15 March 2022
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 12 (2) , 233-237
Covıd-19 tanılı Geriatrik Yoğun Bakım Hastalarında D Vitamini Desteği Sitokin Fırtınasını ve Mortaliteyi Azaltır mı?
Introduction: Coronavirus disease progresses from an asymptomatic stage to a fatal stage characterized by a cytokine storm. Therefore, treatment should focus on enhancing the patients’immune function and preventing cytokine release syndrome. Vitamin-D deficiency is one of the factors triggering cytokine release syndrome. The present study aimed to emphasize the therapeutic effect of vitamin-D supplementation and its potential importance in reducing the disease severity in older adults in the intensive care unit after COVID-19 diagnosis. Materials and Method: The data of 80 patients aged ≥ 65 years who followed up in intensive care clinic. The inflammatory parameters and clinical course of 40 patients whose serum 25-hydroxyvitamin-D level was below 30ng/ml and who received vitamin-D supplementation (case-group) were recorded on the fifth and tenth days of follow-upand compared with those of the other 40 patients who were hospitalized during the initial period of the pandemic and who did not receive vitamin-D supplementation (control-group). Results: Cytokine release syndrome, has developed in the case group rarely. On the 10.day, levels of the inflammatory markers C-reactive protein, procalcitonin, D-dimer, ferritin, interleukin-6, and lactate dehydrogenase were significantly lower and the lymphocyte count was significantly higher in the case group than in the control group. On the 5.day, the interleukin-6 level was significantly lower in the case group. Weaning was performed in nine and four patients in the case and control groups, respectively. There was no significant difference in mortality rates between the groups. Conclusion: Vitamin-D supplementation can help reduce cytokine response. Recommended prophylactically or therapeutically at all stages of coronavirus disease.
- Open Access
- 22 September 2021
- Published by AVES YAYINCILIK A.Ş. in Balkan Medical Journal
- Vol. 38 (5) , 296-303
Clinical Outcomes and Independent Risk Factors for 90-Day Mortality in Critically Ill Patients with Respiratory Failure Infected with SARS-CoV-2: A Multicenter Study in Turkish Intensive Care Units
There are limited data on the long-term outcomes of COVID-19 from different parts of the world. To determine risk factors of 90-day mortality in critically ill patients in Turkish intensive care units (ICUs), with respiratory failure. Retrospective, observational cohort. Patients with laboratory-confirmed COVID-19 and who had been followed up in the ICUs with respiratory failure for more than 24 hours were included in the study. Their demographics, clinical characteristics, laboratory variables, treatment protocols, and survival data were recorded. A total of 421 patients were included. The median age was 67 (IQR: 57-76) years, and 251 patients (59.6%) were men. The 90-day mortality rate was 55.1%. The factors independently associated with 90-day mortality were invasive mechanical ventilation (IMV) (HR 4.09 [95% CI: [2.20-7.63], P < .001), lactate level >2 mmol/L (2.78 [1.93-4.01], P < .001), age ≥60 years (2.45 [1.48-4.06)], P < .001), cardiac arrhythmia during ICU stay (2.01 [1.27-3.20], P = .003), vasopressor treatment (1.94 [1.32-2.84], P = .001), positive fluid balance of ≥600 mL/day (1.68 [1.21-2.34], P = .002), PaO2/FiO2 ratio of ≤150 mmHg (1.66 [1.18-2.32], P = .003), and ECOG score ≥1 (1.42 [1.00-2.02], P = .050). Long-term mortality was high in critically ill patients with COVID-19 hospitalized in intensive care units in Turkey. Invasive mechanical ventilation, lactate level, age, cardiac arrhythmia, vasopressor therapy, positive fluid balance, severe hypoxemia and ECOG score were the independent risk factors for 90-day mortality.
- 22 September 2021
- Published by AVES YAYINCILIK A.Ş. in Balkan Medical Journal
- Vol. 38 (5) , 296-303
Open AccessClinical Outcomes and Independent Risk Factors for 90-Day Mortality in Critically Ill Patients with Respiratory Failure Infected with SARS-CoV-2: A Multicenter Study in Turkish Intensive Care Units
There are limited data on the long-term outcomes of COVID-19 from different parts of the world. To determine risk factors of 90-day mortality in critically ill patients in Turkish intensive care units (ICUs), with respiratory failure. Retrospective, observational cohort. Patients with laboratory-confirmed COVID-19 and who had been followed up in the ICUs with respiratory failure for more than 24 hours were included in the study. Their demographics, clinical characteristics, laboratory variables, treatment protocols, and survival data were recorded. A total of 421 patients were included. The median age was 67 (IQR: 57-76) years, and 251 patients (59.6%) were men. The 90-day mortality rate was 55.1%. The factors independently associated with 90-day mortality were invasive mechanical ventilation (IMV) (HR 4.09 [95% CI: [2.20-7.63], P < .001), lactate level >2 mmol/L (2.78 [1.93-4.01], P < .001), age ≥60 years (2.45 [1.48-4.06)], P < .001), cardiac arrhythmia during ICU stay (2.01 [1.27-3.20], P = .003), vasopressor treatment (1.94 [1.32-2.84], P = .001), positive fluid balance of ≥600 mL/day (1.68 [1.21-2.34], P = .002), PaO2/FiO2 ratio of ≤150 mmHg (1.66 [1.18-2.32], P = .003), and ECOG score ≥1 (1.42 [1.00-2.02], P = .050). Long-term mortality was high in critically ill patients with COVID-19 hospitalized in intensive care units in Turkey. Invasive mechanical ventilation, lactate level, age, cardiac arrhythmia, vasopressor therapy, positive fluid balance, severe hypoxemia and ECOG score were the independent risk factors for 90-day mortality.
- Open Access
- 1 January 2013
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 3 (3) , 1-5
Prevalence of Metabolic Syndrome and Insulin Resistance in Patients with Psoriasis
Aim: Recently, it has been proposed that chronic inflammation in psoriasis lead to metabolic syndrome (MetS) development. There is limited data about the relationship between psoriasis and IR. Aim of the present study was to investigate the prevalence of IR and MetS in psoriasis patients and the association between the severities of illnesses. Methods: The study consisted of 48 psoriasis patients and 45 healthy individuals. IR was estimated using homeostasis model assessment (HOMA) of IR formula. The psoriasis activity was evaluated by the psoriasis area and severity index (PASI). Patients were divided into 3 groups according to PASI scores. Results: MetS was observed in 21 patients (43.75%) and 8 controls (17.77%) (p=0.007). IR was observed in 16 patients (33.33%) and 5 controls (11.11%) (p=0.01). The frequencies of MetS and IR increased in psoriasis patients compared to healthy controls. According to linear regression analysis, PASI was independent risk factor for IR development (p=0.003). Conclusion: The incidences of MetS and IR were found to be higher in patients with psoriasis compared to control group. Especially there was a strong association between severe psoriasis and IR risk. Therefore, psoriasis needs to be considered as not only a skin disorder, but also a metabolic and cardiovascular disease. [J Contemp Med 2014; 4(1.000): 1-5
- 1 January 2013
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 3 (3) , 1-5
Open AccessPrevalence of Metabolic Syndrome and Insulin Resistance in Patients with Psoriasis
Aim: Recently, it has been proposed that chronic inflammation in psoriasis lead to metabolic syndrome (MetS) development. There is limited data about the relationship between psoriasis and IR. Aim of the present study was to investigate the prevalence of IR and MetS in psoriasis patients and the association between the severities of illnesses. Methods: The study consisted of 48 psoriasis patients and 45 healthy individuals. IR was estimated using homeostasis model assessment (HOMA) of IR formula. The psoriasis activity was evaluated by the psoriasis area and severity index (PASI). Patients were divided into 3 groups according to PASI scores. Results: MetS was observed in 21 patients (43.75%) and 8 controls (17.77%) (p=0.007). IR was observed in 16 patients (33.33%) and 5 controls (11.11%) (p=0.01). The frequencies of MetS and IR increased in psoriasis patients compared to healthy controls. According to linear regression analysis, PASI was independent risk factor for IR development (p=0.003). Conclusion: The incidences of MetS and IR were found to be higher in patients with psoriasis compared to control group. Especially there was a strong association between severe psoriasis and IR risk. Therefore, psoriasis needs to be considered as not only a skin disorder, but also a metabolic and cardiovascular disease. [J Contemp Med 2014; 4(1.000): 1-5